Phagocytic immune cell (None (no universally accepted abbreviation for the cell group as a whole; commonly used terms for specific subtypes include "PMN" for polymorphonuclear neutrophil, "Mac" for macrophage, etc., but not for the group itself)[3][4])

Phagocytic immune cells are white blood cells specialized in the engulfment and digestion of pathogens, apoptotic cells, and cellular debris, performing a critical role in both innate and adaptive immune responses. The primary professional phagocytes are neutrophils, macrophages (derived from monocytes), dendritic cells, and eosinophils. These cells recognize targets via surface pattern recognition receptors (PRRs) and opsonin receptors, then ingest and destroy them via specialized mechanisms, including the production of reactive oxygen species and digestive enzymes. Phagocytes also contribute to antigen presentation, tissue homeostasis, and often regulate inflammatory or immune responses. Dysfunction or evasion of phagocytes plays a key role in disease processes, including infections, cancer, autoimmunity, and tissue degeneration[1][2][3][4][5][6][7]. Note: For applications requiring a molecular therapeutic target, a specific receptor (such as "Fc gamma receptor" or "CD47") or a cell-type specific marker (such as "CD68" for macrophages) should be used instead of the broad category "Phagocytic immune cell"[2][3][4].

Other names

PhagocyteProfessional phagocytePhagocytic cellImmune phagocytePhagocytic leukocyte[3][4][9]

Increase or restore phagocytic activity for enhanced pathogen or cancer cell clearance; Block immune evasion signals (e.g., CD47/SIRPα axis); Modulate phagocyte activation (antigen presentation, cytokine release); Reduce inappropriate phagocytosis and inflammation (immunosuppression)[1][5][7]